Cleared Traditional

K921454 - FUKUDA DENSHI MODEL HG-301

K921454 is an FDA 510(k) clearance for FUKUDA DENSHI MODEL HG-301, manufactured by Fukuda Denshi USA, Inc.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 736-day FDA review.

K921454 · Fukuda Denshi USA, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
736d
Days
Class 2
Risk

K921454 is an FDA 510(k) clearance for the FUKUDA DENSHI MODEL HG-301. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Fukuda Denshi USA, Inc. (Redmond, US). The FDA issued a Cleared decision on April 1, 1994 after a review of 736 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Fukuda Denshi USA, Inc. devices

FDA 510(k) Submission Details - K921454

510(k) Number K921454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1992
Decision Date April 01, 1994
Days to Decision 736 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
596d slower than avg
Panel avg: 140d · This submission: 736d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 602
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K921454.
INDEX SPO2 SIMULATOR
K933519 · Bio-Tek Instruments, Inc. · Sep 1994
PULSE OXIMETER
K941289 · Bci Intl., Inc. · Jun 1994
BIOCHEM MODEL 3302 NEWOX2 OXIMETER
K920083 · Biochem International, Inc. · Apr 1994
OXISAT
K934091 · Marquette Electronics, Inc. · Mar 1994
NONIN MEDICAL, INC. FINGER PHANTOM FOR PULSE OXIMETERS
K940463 · Nonin Medical, Inc. · Mar 1994
NOVAMETRIX MODEL 510
K924626 · Novametrix Medical Systems, Inc. · Dec 1993